Long-term evaluation of intermittent levamisole treatment in rheumatoid arthritis
- 1 January 1977
- book chapter
- Published by Springer Nature
- Vol. 4 (1) , 599-609
- https://doi.org/10.1007/978-94-011-7185-4_55
Abstract
Some recent studies have indicated that humoral and cellular immunity could be impaired in RA 1–5. It would therefore seem reasonable to assume that an agent capable of restoring impaired cellular immunity might be of value in treatment of the disease. Keywords Rheumatoid Arthritis White Blood Cell Count Grip Strength Morning Stiffness Total White Blood Cell Count These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.Keywords
This publication has 5 references indexed in Scilit:
- IMMUNOSTIMULANT THERAPY WITH LEVAMISOLE FOR RHEUMATOID ARTHRITISThe Lancet, 1976
- Comparative Study of the In Vitro Proliferative Responses of Blood and Synovial Fluid Leukocytes of Rheumatoid Arthritis PatientsJournal of Clinical Investigation, 1973
- Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritisJournal of Clinical Investigation, 1971
- Serum levels of IgG, IgM, and IgA in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1968
- THERAPEUTIC CRITERIA IN RHEUMATOID ARTHRITISJAMA, 1949